Danaher Corporation (FRA:DAP)
Germany
· Delayed Price · Currency is EUR | Market Cap | 137.57B |
| Revenue (ttm) | 20.75B |
| Net Income (ttm) | 3.00B |
| Shares Out | n/a |
| EPS (ttm) | 4.16 |
| PE Ratio | 45.92 |
| Forward PE | 27.86 |
| Dividend | 1.10 (0.57%) |
| Ex-Dividend Date | Sep 26, 2025 |
| Volume | n/a |
| Average Volume | 568 |
| Open | 195.00 |
| Previous Close | 194.60 |
| Day's Range | 195.00 - 195.00 |
| 52-Week Range | 150.14 - 246.15 |
| Beta | n/a |
| RSI | 56.51 |
| Earnings Date | Jan 28, 2026 |
About Danaher
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. It operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides bioprocessing technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for man... [Read more]
Financial Performance
In 2024, Danaher's revenue was $23.88 billion, a decrease of -0.06% compared to the previous year's $23.89 billion. Earnings were $3.90 billion, a decrease of -17.79%.
Financial numbers in USD Financial StatementsNews
Danaher Stock Earns Relative Strength Rating Upgrade
Danaher shows improving price performance, earning an upgrade to its IBD Relative Strength Rating
6 Dividend Stocks Ready To Benefit From 2026's Rate-Shift Economy
Let's get our 2026 dividend shopping finished ahead of time, shall we?
USCL, BKNG, BSX, DHR: Large Outflows Detected at ETF
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Climate Conscious & Transition MSCI USA ETF (Symbol: USCL) whe...
Jim Cramer has faith in Danaher's turnaround as life sciences comes back to life
Life sciences stocks are seeing a resurgence — and that's good news for Danaher.
Morgan Stanley Initiates Coverage on DHR with Overweight Rating, Sets Price Target at $270 | ...
Morgan Stanley Initiates Coverage on DHR with Overweight Rating, Sets Price Target at $270 | DHR Stock News
Here Are Tuesday’s Top Wall Street Analyst Research Calls: Albemarle, Circle Internet, Cloudflare, Danaher, Inspire Medical, Six Flags, Workday and More
Pre-Market Stock Futures: The futures are trading higher this morning. Sellers regained the upper hand on Monday, starting the final trading month of 2025 on the downside after a blazing Thanksgiving-...
HALPER SADEH LLC ENCOURAGES DANAHER CORPORATION SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS
Shareholders should contact the firm immediately as there may be limited time to enforce your rights. NEW YORK , Nov. 28, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is inves...
Danaher (DHR) Q3 2025 Earnings Call Transcript
Danaher (DHR) Q3 2025 Earnings Call Transcript
DHR Factor-Based Stock Analysis - Martin Zweig
Below is Validea's guru fundamental report for DANAHER CORP (DHR). Of the 22 guru strategies we follow, DHR rates highest using our Growth Investor model based on the published strategy of Martin Zwei...
Here's How Much You Would Have Made Owning Danaher Stock In The Last 10 Years
Danaher (NYSE: DHR) has outperformed the market over the past 10 years by 1.17% on an annualized basis producing an average annual return of 13.51%. Currently, Danaher has a market capitalization of ...
Is Danaher Corp Gaining or Losing Market Support?
Danaher Corp's (NYSE: DHR) short interest as a percent of float has fallen 5.51% since its last report. According to exchange reported data, there are now 7.53 million shares sold short , which is 1....
Notable ETF Inflow Detected - XLV, PFE, DHR, MDT
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the The Health Care Select Sector SPDR Fund (Symbol: XLV) where we have de...
Martin Zweig Detailed Fundamental Analysis - DHR
Below is Validea's guru fundamental report for DANAHER CORP (DHR). Of the 22 guru strategies we follow, DHR rates highest using our Growth Investor model based on the published strategy of Martin Zwei...
DHR Quantitative Stock Analysis - Martin Zweig
Below is Validea's guru fundamental report for DANAHER CORP (DHR). Of the 22 guru strategies we follow, DHR rates highest using our Growth Investor model based on the published strategy of Martin Zwei...
Insider Sell: Teri List Sells 3,298 Shares of Danaher Corp (DHR)
Insider Sell: Teri List Sells 3,298 Shares of Danaher Corp (DHR)
3 More Good Stocks to Invest In After Earnings
These cheap stocks from wide-moat companies look attractive today.
Decoding Danaher's Options Activity: What's the Big Picture?
Financial giants have made a conspicuous bearish move on Danaher. Our analysis of options history for Danaher (NYSE: DHR) revealed 14 unusual trades. Delving into the details, we found 28% of traders...
Danaher Corporation (DHR) Presents at Jefferies London Healthcare Conference 2025 Transcript
Danaher Corporation (DHR) Jefferies London Healthcare Conference 2025 November 18, 2025 6:00 AM ESTCompany ParticipantsRainer Blair - President, CEO &...
Insider Action: Executives unload millions in major stock sales
CNBC’s Frank Holland reports major insider sales at Robinhood, Danaher, Hyatt and Minerals Therapeutics, all confirmed by SEC filings.
The Big 3: TMO, DHR, VLO
As A.I. stocks take a beating on Wednesday's trading session, Dan Deming offers his thoughts and example options trades in healthcare and energy stocks. He explains his bullish theses behind Thermo Fi...
SOLV vs. DHR: Which Stock Is the Better Value Option?
SOLV vs. DHR: Which Stock Is the Better Value Option?
2 Healthcare Stocks for Individual Investors With a 40-Year Time Horizon
A biotech upstart and a life sciences giant could be compelling additions to an investor's portfolio. NovoCure is a high-risk but potentially high-reward bet on industry-changing technology.
Danaher to Present at Jefferies Global Healthcare Conference
WASHINGTON , Nov. 11, 2025 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the Jefferies Global Healthcare ...
SOLV or DHR: Which Is the Better Value Stock Right Now?
SOLV vs. DHR: Which Stock Is the Better Value Option?
Danaher stock may be turning the corner. What needs to happen to keep it that way
Danaher's rebound is generating optimism, but there's still work ahead for the company to hit is 2026 growth targets.